gpt-4o-mini
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.
{
  "first_pass": {
    "id": "chatcmpl-851d892c-803d-445b-82ad-4156f3ece8f9",
    "choices": [
      {
        "finish_reason": "stop",
        "index": 0,
        "logprobs": null,
        "message": {
          "content": "Myanmar does not accept the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations. Instead, Myanmar requires the submission of a dossier in the ASEAN Common Technical Dossier (ACTD) format for all pharmaceutical product registrations. ([rginsight.com](https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai))\n\nThe ACTD format is a standardized structure developed by the Association of Southeast Asian Nations (ASEAN) to streamline the registration process across member countries, including Myanmar. This format consists of four parts:\n\n- **Part I**: Administrative Data\n- **Part II**: Quality Documentation\n- **Part III**: Non-Clinical Study Reports\n- **Part IV**: Clinical Study Reports\n\nEach part is organized to facilitate the evaluation of the pharmaceutical product's safety, efficacy, and quality. ([pharmatutor.org](https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai))\n\nFor innovator pharmaceutical products, Myanmar requires the submission of a complete ACTD dossier, which includes comprehensive data on the product's quality, non-clinical, and clinical aspects. The registration process is managed by the Food and Drug Administration (FDA) Myanmar under the Ministry of Health. Applications must be submitted by a locally licensed company authorized to act as the Marketing Authorization Holder (MAH). ([rginsight.com](https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai))\n\nIn summary, Myanmar does not accept the ICH CTD format for innovator pharmaceutical product registrations. Instead, it mandates the use of the ACTD format for all pharmaceutical product registrations. ",
          "refusal": null,
          "role": "assistant",
          "annotations": [
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 424,
                "start_index": 317,
                "title": "Registration Of Drug Product In Myanmar 2025 | RG Insight",
                "url": "https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai"
              }
            },
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1034,
                "start_index": 922,
                "title": "REGISTRATION DOSSIER OF PHARMACEUTICALS | PharmaTutor",
                "url": "https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai"
              }
            },
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1578,
                "start_index": 1471,
                "title": "Registration Of Drug Product In Myanmar 2025 | RG Insight",
                "url": "https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai"
              }
            }
          ],
          "audio": null,
          "function_call": null,
          "tool_calls": null
        }
      }
    ],
    "created": 1756269970,
    "model": "gpt-4o-mini-search-preview-2025-03-11",
    "object": "chat.completion",
    "service_tier": null,
    "system_fingerprint": "",
    "usage": {
      "completion_tokens": 363,
      "prompt_tokens": 76,
      "total_tokens": 439,
      "completion_tokens_details": {
        "accepted_prediction_tokens": 0,
        "audio_tokens": 0,
        "reasoning_tokens": 0,
        "rejected_prediction_tokens": 0
      },
      "prompt_tokens_details": {
        "audio_tokens": 0,
        "cached_tokens": 0
      }
    }
  },
  "second_pass": {
    "id": "resp_68ae8d9722f8819eaea274642f78c0d90381f45636726123",
    "created_at": 1756269975.0,
    "error": null,
    "incomplete_details": null,
    "instructions": null,
    "metadata": {},
    "model": "gpt-4o-mini-2024-07-18",
    "object": "response",
    "output": [
      {
        "id": "msg_68ae8d977d30819eb33000d11b1f0bc20381f45636726123",
        "content": [
          {
            "annotations": [],
            "text": "{\"status\":\"NO\",\"explanation\":\"Myanmar does not accept the ICH CTD format for innovator pharmaceutical product registrations, requiring instead the ASEAN Common Technical Dossier (ACTD) format.\",\"sources\":[\"https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai\",\"https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai\"]}",
            "type": "output_text",
            "logprobs": [],
            "parsed": {
              "status": "NO",
              "explanation": "Myanmar does not accept the ICH CTD format for innovator pharmaceutical product registrations, requiring instead the ASEAN Common Technical Dossier (ACTD) format.",
              "sources": [
                "https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai",
                "https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai"
              ]
            }
          }
        ],
        "role": "assistant",
        "status": "completed",
        "type": "message"
      }
    ],
    "parallel_tool_calls": true,
    "temperature": 1.0,
    "tool_choice": "auto",
    "tools": [],
    "top_p": 1.0,
    "background": false,
    "conversation": null,
    "max_output_tokens": null,
    "max_tool_calls": null,
    "previous_response_id": null,
    "prompt": null,
    "prompt_cache_key": null,
    "reasoning": {
      "effort": null,
      "generate_summary": null,
      "summary": null
    },
    "safety_identifier": null,
    "service_tier": "default",
    "status": "completed",
    "text": {
      "format": {
        "name": "QueryResponse",
        "schema_": {
          "$defs": {
            "Status": {
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            }
          },
          "properties": {
            "status": {
              "description": "Status of the policy for the given country",
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            },
            "explanation": {
              "description": "1 sentence explanation of the status with citations",
              "title": "Explanation",
              "type": "string"
            },
            "sources": {
              "description": "A list of URLs cited in the explanation",
              "items": {
                "type": "string"
              },
              "title": "Sources",
              "type": "array"
            }
          },
          "required": [
            "status",
            "explanation",
            "sources"
          ],
          "title": "QueryResponse",
          "type": "object",
          "additionalProperties": false
        },
        "type": "json_schema",
        "description": null,
        "strict": true
      },
      "verbosity": "medium"
    },
    "top_logprobs": 0,
    "truncation": "disabled",
    "usage": {
      "input_tokens": 1525,
      "input_tokens_details": {
        "cached_tokens": 0
      },
      "output_tokens": 91,
      "output_tokens_details": {
        "reasoning_tokens": 0
      },
      "total_tokens": 1616
    },
    "user": null,
    "store": true
  }
}